Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway

Current Opinion in Lipidology

Volumn 16, Issue 3, 2005, Pages 269-279

  Yokoyama, Shinji ^a,b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

ABCA1; Apolipoprotein; Caveolin; Cholesterol efflux; HDL; Membrane

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ABC TRANSPORTER A1; ANTILIPEMIC AGENT; APOLIPOPROTEIN; CALPAIN; CALPASTATIN; CALPEPTIN; CAVEOLIN 1; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CYSTEINE PROTEINASE INHIBITOR; FENOFIBRIC ACID; HIGH DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPID; PIRINIXIC ACID; PROBUCOL; PROTEIN KINASE C INHIBITOR; STEROL; TRANSCRIPTION FACTOR; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

CELL SURFACE; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DIFFUSION; ENZYME ACTIVATION; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FUNCTION; REACTION ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; TANGIER DISEASE; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 20544449485     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000169346.15450.90     Document Type: Review

References (132)

1. Bjorkhem I, Andersson O, Diczfalusy U, et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci U S A 1994; 91:8592-8596.
2. Babiker A, Andersson O, Lund E, et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism: comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 1997; 272:26253-26261.
3. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232:34-47.
4. Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 1999; 96:11041-11048.
5. Norton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109:1125-1131.
6. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
7. Ng DS, Francone OL, Forte TM, et al. Disruption of the murine lecithin: cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I. J Biol Chem 1997; 272:15777-15781.
8. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36:211-228.
9. Gordon DJ, Rifkind BM. High density lipoprotein - the clinical implications of recent studies. N Engl J Med 1989; 321:1311-1316.
10. Ho YK, Brown MS, Goldstein JL. Hydrolysis and excretion of cytoplasmic cholesterol esters by macrophages: stimulation by high density lipoprotein and other agents. J Lipid Res 1980; 21:391-398.
11. Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 1996; 37:2473-2491.
12. Yokoyama S. Apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta 1998; 1392:1-15.
13. Yokoyama S. Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim Biophys Acta 2000; 1529:231-244.
14. Ji Y, Jian B, Wang N, et al. Scavenger receptor B1 promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272: 20982-20985.
15. de La Llera-Moya M, Connelly MA, Drazul D, et al. Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J Lipid Res 2001; 42:1969-1978.
16. Wang N, Lan D, Chen W, et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004; 101:9774-9779. This paper shows that ABCG1 and ABCG4 alters cholesterol distribution in cells for the promotion of its 'efflux' to HDL seemingly through non-specific exchange.
17. Hara H, Yokoyama S. Interaction of free apolipoprotein with macrophages: formation of high density lipoprotien-like lipoproteins and reduction of cellular cholesterol. J Biol Chem 1991; 266:3080-3086.
18. Forte TM, Goth-Goldstein R, Nordhausen RW, McCall MR. Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res 1993; 34:317-324.
19. Forte TM, Bielicki JK, Knoff L, McCall MR. Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture. J Lipid Res 1996; 37:1076-1085.
20. Czarnecka H, Yokoyama S. Lecithin: cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry 1995; 34:4385-4392.
21. Forte TM, Bielicki JK, Goth-Goldstein R, et al. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J Lipid Res 1995; 36:148-157.
22. Hara H, Hara H, Komaba A, Yokoyama S. α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids 1992; 27:302-304.
23. Yancey PG, Bielicki JK, Johnson WJ, et al. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 1995; 34:7955-7965.
24. Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest 1994; 94:1698-1705.
25. Remaley AT, Thomas F, Stonik JA, et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res 2003; 44:828-836.
26. Li Q, Komaba A, Yokoyama S. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry 1993; 32:4597-4603.
27. Czarnecka H, Yokoyama S. Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem 1996; 271:2023-2028.
28. Li Q, Czarnecka H, Yokoyama S. Involvement of cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta 1995; 1259:227-234.
29. Karlin JB, Johnson WJ, Benedict CR, et al. Cholesterol flux between cells and high density lipoprotein: lack of relationship to specific binding of the lipoprotein to the cell surface. J Biol Chem 1987; 262:12557-12564.
30. Sakr SW, Williams DL, Stoudt GW, et al. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim Biophys Acta 1999; 1438:85-98.
31. Smith JD, Miyata M, Ginsberg M, et al. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from macrophage cell line to apolipoprotein acceptors. J Biol Chem 1996; 271:30647-30655.
32. Takahashi Y, Smith JD. Cholesterol efflux to apolipoprotein A-I involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci U S A 1999; 96:11358-11363.
33. Mendez AJ, Uint L. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J Lipid Res 1996; 37:2510-2524.
34. Tsujita M, Yokoyama S. Selective inhibition of free apolipoprotein- mediated cellular lipid efflux by probucol. Biochemistry 1996; 35:13011-13020.
35. Tsujita M, Tomimoto S, Okumura-Noji K, et al. Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice. Biochim Biophys Acta 2000; 1485:199-213.
36. Assmann G, von Eckardstein A, Brewer HB Jr. Familial analphalipoproteinemia: Tangier disease. In: Scriver CR, Beaudet AC, Valle D, Sly WS, editors. The metabolic and molecular basis of inherited disease, 8th ed. New York: McGraw-Hill; 2001. pp. 2937-2960.
37. Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 1995; 96:78-87.
38. Remaley AT, Schumacher UK, Stonik JA, et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts: acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 1997; 17:1813-1821.
39. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22:336-345.
40. Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22:347-351.
41. Rust S, Rosier M, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP binding-cassette transporter 1. Nat Genet 1999; 22:352-355.
42. Lawn RM, Wade DP, Garvin MR, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999; 104:R25-R31.
43. Remaley AT, Rust S, Rosier M, et al. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci USA 1999; 96:12685-12690.
44. Marcil M, Brooks-Wilson A, Clee SM, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999; 354:1341-1346.
45. Orso E, Broccardo C, Kaminski WE, et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and abc1-deficient mice. Nat Genet 2000; 24:192-196.
46. McNeish J, Aiello RJ, Guyot D, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci U S A 2000; 97:4245-4250.
47. Abe-Dohmae S, Suzuki S, Wada Y, et al. Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry 2000; 39:11092-11099.
48. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000; 275:34508-34511.
49. Wang N, Silver DL, Costet P, Tall AR. Specific binding of apoA-1, enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000; 275:33053-33058.
50. Fitzgerald ML, Morris AL, Chroni A, et al. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res 2004; 45:287-294. This paper demonstrates the competitiveness of the direct interaction with ABCA1 among helical apolipoproteins for the removal of cellular cholesterol.
51. Singaraja RR, Brunham LR, Visscher H, et al. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003; 23:1322-1332. An excellent summary of the mutations in ABCA1 that lead to HDL deficiency.
52. Abe-Dohmae S, Ikeda Y, Matsuo M, et al. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J Biol Chem 2004; 279:604-611. This paper reports that ABCA7 mediates the apolipoprotein-induced release of cellular phospholipid and cholesterol.
53. Wang N, Lan D, Gerbod-Giannone M, et al. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem 2003; 278:42906-42912. This paper reports that ABCA7 mediates the apolipoprotein-induced release of cellular phospholipid.
54. Jonas A. Reconstitution of high-density lipoproteins. Meth Enzymol 1986; 128:553-582.
55. Li Q, Tsujita M, Yokoyama S. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 1997; 36:12045-12052.
56. Wu C-A, Tsujita M, Hayashi M, Yokoyama S. Probucol inactivates ABCA1 in plasma membrane for its function to mediate apolipoprotein binding and HDL assembly and for its proteolytic degradation. J Biol Chem 2004; 279:30168-30174. This paper shows that probucol inactivates ABCA1 in the plasma membrane and at the same time stabilizes it against calpain.
57. Ito J, Zhang L, Asai M, Yokoyama S. Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes. J Neurochem 1999; 72:2362-2369.
58. Li Q, Yokoyama S. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J Biol Chem 1995; 270:26216-26223.
59. Komaba A, Li Q, Hara H, Yokoyama S. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apotipoproteins and to reduction of intracellularly accumulated cholesterol. J Biol Chem 1992; 267:17560-17566.
60. Arakawa R, Abe-Dohmae S, Asai M, et al. Involvement of caveolin-1 in cholesterol-enrichment of HDL during its assembly by apolipoprotein and THP-1 cells. J Lipid Res 2000; 41:1952-1962.
61. Ito J, Nagayasu Y, Yokoyama S. Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux. J Lipid Res 2000; 41:894-904.
62. Yamauchi Y, Abe-Dohmae S, Yokoyama S. Differential regulation of apolipoprotein A-I/ATP binding cassette transporter A1-mediated cholesterol and phospholipid release. Biochim Biophys Acta 2002; 1585:1-10.
63. Bielicki JK, Johnson WJ, Weinberg RB, et al. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res 1992; 33:1699-1709.
64. Bielicki JK, McCall MR, Forte TM. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. J Lipid Res 1999; 40:85-92.
65. Mendez AJ, Oram JF, Bierman EL. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 1991; 266:10104-10111.
66. Francis GA, Mendez AJ, Bierman EL, Heinecke JW. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc Natl Acad Sci U S A 1993; 90:6631-6635.
67. Francis GA, Oram JF, Heinecke JW, Bierman EL. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry 1996; 35:15188-15197.
68. Wang WQ, Merriam DL, Moses AS, Francis GA. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-All heterodimers. J Biol Chem 1998; 273:17391-17398.
69. Sviridov D, Fidge N. Efflux of intracellular versus plasma membrane cholesterol in HepG cells: different availability and regulation by apolipoprotein A-I. J Lipid Res 1995; 36:1887-1896.
70. Regler G, Trumbach B, Klima B, et al. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol 1995; 15:683-690.
71. Boyles JK, Pitas RE, Wilson E, et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985; 76:1501-1513.
72. Nakai M, Kawamata T, Maeda K, Tanaka C. Expression of apoE mRNA in rat microglia. Neurosci Lett 1996; 211:41-44.
73. Fielding PE, Fielding CJ. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 1995; 34:14288-14292.
74. Parton RG, Simons K. Digging into caveolae. Science 1995; 269:1398-1399.
75. Smart EJ, Ying Y-S, Conrad PA, Anderson RGW. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 1994; 127:1185-1197.
76. Fielding CJ, Bist A, Fielding PE. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblasts monolayers. Proc Natl Acad Sci U S A 1997; 94:3753-3758.
77. Bist A, Fielding PE, Fielding CJ. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci U S A 1997; 94:10693-10698.
78. Smart EJ, Ying Y-S, Donzell WC, Anderson RGW. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 1996; 271:29427-29435.
79. Uittenbogaard A, Ying Y-S, Smart EJ. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex: involvement in cholesterol trafficking. J Biol Chem 1998; 273:6525-6532.
80. Ito J, Nagayasu Y, Kato K, et al. Apolipoprotein A-I induces translocation of cholesterol, phospholipid and caveolin-1 to cytosol in rat astrocytes. J Biol Chem 2002; 277:7929-7935.
81. Ito J, Li H, Nagayasu Y, et al. Apolipoprotein A-I induces translocation of protein kinase Ca to a cytosolic lipid-protein particle in astrocytes. J Lipid Res 2004; 45:2269-2276. This paper presents a new intracellular signaling device that is related to apoA-I-induced lipid release in astrocytes.
82. Bell-Quint J, Forte T. Time-related changes in the synthesis and secretion of very low density, low density and high density lipoproteins by cultured rat hepatocytes. Biochim Biophys Acta 1981; 663:83-98.
83. Cheung MC, Lum KD, Brouillette CG, Bisgaier CL. Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells. J Lipid Res 1989; 30:1429-1436.
84. Sorci-Thomas M, Prack MM, Dashti N, et al. Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia. J Biol Chem 1988; 263:5183-5189.
85. Sorci-Thomas M, Prack MM, Dashti N, et al. Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. J Lipid Res 1989; 30:1397-1403.
86. Zhang W-Y, Gaynor PM, Kruth HS. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem 1996; 271:28641-28646.
87. Tsujita M, Wu C-A, Abe-Dohmae S, et al. On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway. J Lipid Res 2005; 46:154-162. This paper shows that apoA-I generates HDL with the cellular lipid of HepG2 cells in an autocrine manner.
88. Okuhira K, Tsujita M, Yamauchi Y, et al. Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL. J Lipid Res 2004; 45:645-652. This paper reports that apoA-I dissociates from HDL to interact with cells to generate HDL by the ABCA1 pathway.
89. Chisholm JW, Burleson ER, Shelness GS, Parks JS. ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL J Lipid Res 2002; 43:36-44.
90. Kiss RS, McManus DC, Franklin V, et al. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways. J Biol Chem 2003; 278:10119-10127. This paper demonstrates the possibility of an ABCA1-independent pathway for HDL biogenesis in hepatocytes.
91. Fielding CJ, Fielding PE. Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin: cholesterol acyltransferase. Proc Natl Acad Sci U S A 1981; 78:3911-3914.
92. Kilsdonk EPC, Dorsman ANRD, van Tol A. Effect of LCAT on HDL-mediated cholesterol efflux from loaded EA.hy 926 cells. Int J Biochem 1993; 25:219-221.
93. Oram JF, Mendez AJ, Slotte JP, Johnson TF. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler Thromb 1991; 11:403-414.
94. Glomset JA. The lecithin: cholesterol acyltransferase reaction. J Lipid Res 1968; 9:155-167.
95. Hara H, Yokoyama S. Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-β high-density lipoprotein pathway. Biochemistry 1992; 31:2040-2046.
96. Tajima S, Yokoyama S, Yamamoto A. Effect of lipid particle size on association of apolipoproteins with lipid. J Biol Chem 1983; 258:10073-10082.
97. Okabe H, Yokoyama S, Yamamoto A. Modulation of cholesterol micro-environment with apolipoproteins induced by the presence of cholesteryl ester in lipid microemulsion. J Biochem 1988; 104:141-148.
98. Liang H-Q, Rye K-A, Barter PJ. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J Lipid Res 1994; 35:1187-1199.
99. Liang H-Q, Rye K-A, Barter PJ, Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim Biophys Acta 1995; 1257:31 37.
100. Clay MA, Newnham HH, Forte TM, Barter PI. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL Biochim Biophys Acta 1992; 1124:52-58.
101. Pussinen P, Juahiainen M, Metso J, et al. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res 1995; 36:975-985.
102. Wolfbauer G, Albers JJ, Oram JF. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta 1999; 1439:65-76.
103. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry 1988; 27:25-29.
104. Miida T, Kawano M, Fielding CJ, Fielding PE. Regulation of the concentration of preβ high density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry 1992; 31:11112-11117.
105. Kuwano M, Miida T, Fielding CJ, Fielding PE. Quantitation of preβ-HDL and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry 1993; 32:5025-5028.
106. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000; 275:28240-28245.
107. Schwartz K, Lawn RM, Wade DP. ABC1 gene expression and apoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 2000; 274:794-802.
108. Venkateswaran A, Laffitte BA, Joseph SB, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 2000; 97:12097-12102.
109. Costet P, Lalanne F, Gerbod-Giannone MC, et al. Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol Cell Biol 2003; 23:7756-7766. This paper provides further evidence of the involvement of RXR in the transcriptional regulation of ABCA1.
110. Langmann T, Klucken J, Reil M, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophage. Biochem Biophys Res Commun 1999; 257:29-33.
111. Sparrow CP, Baffic J, Lam MH, et al. A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux. J Biol Chem 2002; 277:10021-10027.
112. Chinetti G, Lestavel S, Bocher V, et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001; 1:53-58.
113. Arakawa R, Tamehiro N, Nishimaki-Mogami T, et al. Fenofibric acid, an active form of fenofibrate, increases apoA-I-mediated HDL biogenesis by enhancing transcription of ABCA1 gene in an LXR-dependent manner. Arterioscler Thromb Vasc Biol 2005; in press.
114. Lin G, Bornfeldt KE. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. Biochem Biophys Res Commun 2002; 290:663-669.
115. Suzuki S, Nishimaki-Mogami T, Tamehiro N, et al. Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism. Arterioscler Thromb Vasc Biol 2004; 24:519-525. A demonstration of the transcriptional activation of ABCA1 by a clinically used calcium antagonist that is independent of the LXR/RXR pathway.
116. Miao B, Zondlo S, Gibbs S, et al. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res 2004; 45:1410-1417. A report on an LXR agonist that raised HDL without interfering with fatty acid metabolism.
117. Arakawa R, Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem 2002; 277:22426-22429.
118. Wang N, Chen W, Linsel-Nitschke P, et al. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 2003; 111:99-107. This paper reports that apoA-I suppresses the calpain-mediated degradation of ABCA1, after Ref. [117].
119. Yamauchi Y, Hayashi M, Abe-Dohmae S, Yokoyama S. Apolipoprotein A-I activates protein kinase Ca signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J Biol Chem 2003; 278:47890-47897. This paper demonstrates that the removal of apoA-I-mediated sphingomyelin triggers the PKC-related cellular signaling to lead to phosphorylation and stabilization of ABCA1 against calpain.
120. Arakawa R, Hayashi M, Remaley AT, et al. Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides. J Biol Chem 2004; 279:6217-6220. This report shows phosphorylation and stabilization of ABCA1 against calpain induced by synthetic helical amphiphilic peptides.
121. Ito J, Nagayasu Y, Ueno S, Yokoyama S. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine- specific phospholipase C-dependent manner. J Biol Chem 2002; 277: 44709-44714.
122. Yamauchi Y, Chang CC, Hayashi M, et al. Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts. J Lipid Res 2004; 45:1943-1951. This paper shows the involvement of ACAT in the regulation of ABCA1 transcriptional and cholesterol trafficking to the HDL assembly.
123. Martinez LO, Agerholm-Larsen B, Wang N, et al. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 2003; 278:37368-37374. A report that apoA-I suppresses the phosphorylation of ABCA1 at the PEST sequence to protect it against calpain.
124. Yamamoto A, Matsuzawa Y, Yokoyama S, et al. Effects of probucol on xanthomata regression in familial hypercholesterolemia. Am J Cardiol 1986; 57:29H-35H.
125. Kita T, Nagano Y, Yokode M, et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A1987; 84:5928-5931.
126. Sasahara M, Raines EW, Chait A, et al. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. 1. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest 1994; 94:155-164.
127. Yokoyama S, Yamamoto A, Kurasawa T. A little more information about aggravation of probucol-induced HDL-reduction by clofibrate. Atherosclerosis 1988; 70:179-181.
128. 2b by probucol partly explains the failure of the drug to affect femoral atheroscelrosis in subjects with hypercholesterolemia: a Probucol Quantitative Regression Swedish Trial (PQRST) Report. Arterioscler Thromb Vasc Biol 1995; 15: 1049-1056.
129. Favari E, Zanotti I, Zimetti F, et al. Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler Thromb Vasc Biol 2004; 24:2345-2350. This paper reports that probucol interferes with ABCA trafficking.
130. Le Goff W, Peng DQ, Settle M, et al. Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004; 24:2155-2161. This paper shows that cyclosporine A inactivates ABCA1 in a similar manner to that shown for probucol in Ref. [56].
131. Glomset JA, Assmann G, Gjone E, Norum KR. Lecithin: cholesterol acyltransferase deficiency and fish eye disease. 7th ed. In: Sciver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, II. New York: McGraw-Hill, Inc. Health Profession Division; 1995. pp.1933-1952.
132. Tomimoto S, Tsujita M, Okazaki M, et al. Effect of probucol in lecithin-cholesterol acyltransferase deficient mice: inhibition of two independent cellular cholesterol releasing pathways in vivo. Arterioscler Thromb Vasc Biol 2001; 21:394-400.